Tonix Shares Rise 5% on GPO Deal

Tonix Pharmaceuticals' stock climbed about 5.1% after announcing a group purchasing organization coverage agreement effective May 1.
The deal grants access to roughly 35 million U.S. commercial lives, about 20% of the 177 million commercial lives nationwide.
TONMYA, a first‑in‑class non‑opioid fibromyalgia tablet launched Nov 2025, is now covered for Medicaid in 38 states covering 55 million lives (73% of Medicaid).
Discussions with Medicare and Medicaid continue to expand coverage.